Bètablokkers ter preventie van decompensatie van cirrose bij patiënten met portale hypertensie

Bronnen:

1. Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019 Mar 22. pii: S0140-6736(18)31875-0. [Epub ahead of print]